| Dr Fen Wang, MD | |
|
3901 Rainbow Blvd, Mail Stop 4033, Kansas City, KS 66160-0001 | |
| (913) 588-3644 | |
| (913) 588-3663 |
| Full Name | Dr Fen Wang |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 40 Years |
| Location | 3901 Rainbow Blvd, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598830176 | NPI | - | NPPES |
| 31416011 | Other | BCBS KANSAS CITY | |
| 100421420A | Medicaid | KS | |
| 100421420D | Medicaid | KS | |
| 205924301 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 04-29788 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Kansas Hospital | Kansas city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
| University Of Kansas Hospital Authority | 9436054798 | 250 |
| University Of Kansas Hospital Authority | 9436054798 | 250 |
News Archive
In this study, researchers aimed at finding the minimum vaccination rate for each age group that guaranteed the basic reproduction number R0 was less than 1, thus stabilizing the dynamics at the disease-free equilibrium.
Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator.
Cipher Pharmaceuticals Inc. today announced that the U.S. Patent and Trademark Office has issued a Patent Notice of Allowance for CIP-TRAMADOL ER, the Company's extended-release tramadol product for the treatment of moderate to moderately severe chronic pain in adults.
Most complex diseases, such as obesity, longevity, and diabetes, are largely influenced by genetic factors. But at the same time, they are also modulated by environmental stimuli, such as diet and physical activity.
None of us want to experience events like the Camelford water pollution incident in Cornwall, England, in the late eighties, or more recently, the Crestwood, Illinois, water contamination episode in 2009 where accidental pollution of drinking water led to heart-wrenching consequences to consumers, including brain damage, high cancer risk, and even death. In the case of such catastrophes, it is important to have a method to identify and curtail contaminations immediately to minimize impact on the public.
› Verified 5 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
In this study, researchers aimed at finding the minimum vaccination rate for each age group that guaranteed the basic reproduction number R0 was less than 1, thus stabilizing the dynamics at the disease-free equilibrium.
Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator.
Cipher Pharmaceuticals Inc. today announced that the U.S. Patent and Trademark Office has issued a Patent Notice of Allowance for CIP-TRAMADOL ER, the Company's extended-release tramadol product for the treatment of moderate to moderately severe chronic pain in adults.
Most complex diseases, such as obesity, longevity, and diabetes, are largely influenced by genetic factors. But at the same time, they are also modulated by environmental stimuli, such as diet and physical activity.
None of us want to experience events like the Camelford water pollution incident in Cornwall, England, in the late eighties, or more recently, the Crestwood, Illinois, water contamination episode in 2009 where accidental pollution of drinking water led to heart-wrenching consequences to consumers, including brain damage, high cancer risk, and even death. In the case of such catastrophes, it is important to have a method to identify and curtail contaminations immediately to minimize impact on the public.
› Verified 5 days ago
| Entity Name | University Of Kansas Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528019502 PECOS PAC ID: 9436054798 Enrollment ID: O20050908001103 |
News Archive
In this study, researchers aimed at finding the minimum vaccination rate for each age group that guaranteed the basic reproduction number R0 was less than 1, thus stabilizing the dynamics at the disease-free equilibrium.
Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator.
Cipher Pharmaceuticals Inc. today announced that the U.S. Patent and Trademark Office has issued a Patent Notice of Allowance for CIP-TRAMADOL ER, the Company's extended-release tramadol product for the treatment of moderate to moderately severe chronic pain in adults.
Most complex diseases, such as obesity, longevity, and diabetes, are largely influenced by genetic factors. But at the same time, they are also modulated by environmental stimuli, such as diet and physical activity.
None of us want to experience events like the Camelford water pollution incident in Cornwall, England, in the late eighties, or more recently, the Crestwood, Illinois, water contamination episode in 2009 where accidental pollution of drinking water led to heart-wrenching consequences to consumers, including brain damage, high cancer risk, and even death. In the case of such catastrophes, it is important to have a method to identify and curtail contaminations immediately to minimize impact on the public.
› Verified 5 days ago
| Entity Name | Topeka Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770008849 PECOS PAC ID: 6406112473 Enrollment ID: O20171107002163 |
News Archive
In this study, researchers aimed at finding the minimum vaccination rate for each age group that guaranteed the basic reproduction number R0 was less than 1, thus stabilizing the dynamics at the disease-free equilibrium.
Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator.
Cipher Pharmaceuticals Inc. today announced that the U.S. Patent and Trademark Office has issued a Patent Notice of Allowance for CIP-TRAMADOL ER, the Company's extended-release tramadol product for the treatment of moderate to moderately severe chronic pain in adults.
Most complex diseases, such as obesity, longevity, and diabetes, are largely influenced by genetic factors. But at the same time, they are also modulated by environmental stimuli, such as diet and physical activity.
None of us want to experience events like the Camelford water pollution incident in Cornwall, England, in the late eighties, or more recently, the Crestwood, Illinois, water contamination episode in 2009 where accidental pollution of drinking water led to heart-wrenching consequences to consumers, including brain damage, high cancer risk, and even death. In the case of such catastrophes, it is important to have a method to identify and curtail contaminations immediately to minimize impact on the public.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fen Wang, MD Po Box 411851, Kansas City, MO 64141-1851 Ph: (913) 588-3644 | Dr Fen Wang, MD 3901 Rainbow Blvd, Mail Stop 4033, Kansas City, KS 66160-0001 Ph: (913) 588-3644 |
News Archive
In this study, researchers aimed at finding the minimum vaccination rate for each age group that guaranteed the basic reproduction number R0 was less than 1, thus stabilizing the dynamics at the disease-free equilibrium.
Abide Therapeutics, a developer of innovative pharmaceuticals, announced today initiation of enrollment and dosing of the first subject in a Phase 1a clinical study of ABX-1431, a first-in-class, investigational endocannabinoid system modulator.
Cipher Pharmaceuticals Inc. today announced that the U.S. Patent and Trademark Office has issued a Patent Notice of Allowance for CIP-TRAMADOL ER, the Company's extended-release tramadol product for the treatment of moderate to moderately severe chronic pain in adults.
Most complex diseases, such as obesity, longevity, and diabetes, are largely influenced by genetic factors. But at the same time, they are also modulated by environmental stimuli, such as diet and physical activity.
None of us want to experience events like the Camelford water pollution incident in Cornwall, England, in the late eighties, or more recently, the Crestwood, Illinois, water contamination episode in 2009 where accidental pollution of drinking water led to heart-wrenching consequences to consumers, including brain damage, high cancer risk, and even death. In the case of such catastrophes, it is important to have a method to identify and curtail contaminations immediately to minimize impact on the public.
› Verified 5 days ago
Dr. Benjamin Adam Schatz, MD Radiology Medicare: Medicare Enrolled Practice Location: 3901 Rainbow Blvd # Ms 4032, Kansas City, KS 66160 Phone: 405-416-0500 | |
Pauline R Sleder, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6805 | |
Dr. Steven Mclain Lemons, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd # Ms 4032, Kansas City, KS 66160 Phone: 913-588-6805 | |
Philip L Johnson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Mail Stop 4032, Kansas City, KS 66160 Phone: 913-588-6800 Fax: 913-588-7899 | |
Dr. Ernest John Madarang, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Department Of Radiology, Kansas City, KS 66103 Phone: 913-588-6875 | |
Norman L Martin, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 3901 Rainbow Blvd, Mail Stop 4032, Kansas City, KS 66160 Phone: 913-588-6800 Fax: 913-588-7899 | |
Irfanullah Haider, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Ms 4032, Kansas City, KS 66160 Phone: 913-588-5000 |